4basebio says "tier one" partner tests vaccine from its template
(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More
| Price | 712.50p on 02-12-2025 at 06:00:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Sell 5.00 at 701.00p |
| Day's Volume: | 0 |
| Last Close: | 712.50p |
| Open: | 0.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 650.00p - 1,300.00p |
| Market Capitalisation: | £110.33m |
| VWAP: | 0.00p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 5 | 701.00p | Ordinary |
12:33:38 - 28-Nov-25 |
| Sell* | 46 | 708.25p | Ordinary |
10:09:47 - 28-Nov-25 |
| Sell* | 14 | 708.25p | Ordinary |
08:30:08 - 27-Nov-25 |
| Sell* | 14 | 708.45p | Ordinary |
08:16:58 - 26-Nov-25 |
| Sell* | 1 | 700.00p | Ordinary |
08:04:30 - 26-Nov-25 |
| Sell* | 88 | 700.25p | Ordinary |
08:22:10 - 25-Nov-25 |
| Sell* | 500 | 700.25p | Ordinary |
08:22:01 - 25-Nov-25 |
| Sell* | 11 | 701.00p | Ordinary |
15:01:28 - 24-Nov-25 |
| Sell* | 42 | 708.45p | Ordinary |
13:38:12 - 24-Nov-25 |
| Buy* | 15 | 715.00p | Suspected BUY Trade |
09:00:10 - 24-Nov-25 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |